| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | orexin receptor activity | 3.72e-06 | 2 | 39 | 2 | GO:0016499 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 5.03e-04 | 190 | 39 | 4 | GO:0004252 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 6.94e-04 | 207 | 39 | 4 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 7.59e-04 | 212 | 39 | 4 | GO:0017171 | |
| Domain | BMP_1/tolloid-like | 7.77e-09 | 3 | 38 | 3 | IPR015446 | |
| Domain | Peptidase_M12A | 1.55e-07 | 6 | 38 | 3 | IPR001506 | |
| Domain | Astacin | 1.55e-07 | 6 | 38 | 3 | PF01400 | |
| Domain | Orexin_rcpt | 4.03e-06 | 2 | 38 | 2 | IPR000204 | |
| Domain | ZnMc | 2.74e-05 | 29 | 38 | 3 | SM00235 | |
| Domain | Peptidase_Metallo | 2.74e-05 | 29 | 38 | 3 | IPR006026 | |
| Domain | WD40_repeat_dom | 2.77e-05 | 297 | 38 | 6 | IPR017986 | |
| Domain | - | 5.24e-05 | 333 | 38 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 5.42e-05 | 335 | 38 | 6 | IPR015943 | |
| Domain | CUB | 1.34e-04 | 49 | 38 | 3 | PF00431 | |
| Domain | CUB | 1.43e-04 | 50 | 38 | 3 | SM00042 | |
| Domain | - | 1.60e-04 | 52 | 38 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.70e-04 | 53 | 38 | 3 | PS01180 | |
| Domain | WD40 | 1.70e-04 | 259 | 38 | 5 | PF00400 | |
| Domain | WD40 | 2.00e-04 | 268 | 38 | 5 | SM00320 | |
| Domain | CUB_dom | 2.11e-04 | 57 | 38 | 3 | IPR000859 | |
| Domain | WD40_repeat | 2.14e-04 | 272 | 38 | 5 | IPR001680 | |
| Domain | WD_REPEATS_1 | 2.37e-04 | 278 | 38 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.41e-04 | 279 | 38 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.41e-04 | 279 | 38 | 5 | PS50294 | |
| Domain | WD40_repeat_CS | 3.35e-04 | 164 | 38 | 4 | IPR019775 | |
| Domain | MetalloPept_cat_dom | 5.94e-04 | 81 | 38 | 3 | IPR024079 | |
| Domain | - | 5.94e-04 | 81 | 38 | 3 | 3.40.390.10 | |
| Domain | EGF_CA | 7.08e-04 | 86 | 38 | 3 | PF07645 | |
| Domain | Apc4_WD40_dom | 7.48e-04 | 20 | 38 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 7.48e-04 | 20 | 38 | 2 | PF12894 | |
| Domain | EGF_Ca-bd_CS | 1.00e-03 | 97 | 38 | 3 | IPR018097 | |
| Domain | ZINC_PROTEASE | 1.03e-03 | 98 | 38 | 3 | PS00142 | |
| Domain | EGF_CA | 1.07e-03 | 99 | 38 | 3 | PS01187 | |
| Domain | EGF_3 | 1.29e-03 | 235 | 38 | 4 | PS50026 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.30e-03 | 106 | 38 | 3 | IPR000152 | |
| Domain | EGF-like_dom | 1.59e-03 | 249 | 38 | 4 | IPR000742 | |
| Domain | EGF_CA | 1.94e-03 | 122 | 38 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.03e-03 | 124 | 38 | 3 | IPR001881 | |
| Domain | EGF | 2.13e-03 | 126 | 38 | 3 | PF00008 | |
| Domain | ConA-like_dom | 9.92e-03 | 219 | 38 | 3 | IPR013320 | |
| Domain | EGF | 1.20e-02 | 235 | 38 | 3 | SM00181 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.72e-06 | 15 | 34 | 3 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.02e-05 | 18 | 34 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.02e-05 | 18 | 34 | 3 | MM14882 | |
| Pathway | WP_SLEEP_REGULATION | 1.02e-04 | 38 | 34 | 3 | M39504 | |
| Pathway | REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS | 1.57e-04 | 8 | 34 | 2 | M27291 | |
| Pathway | REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS | 1.57e-04 | 8 | 34 | 2 | MM14995 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.33e-04 | 50 | 34 | 3 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.19e-04 | 61 | 34 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.19e-04 | 61 | 34 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.53e-04 | 67 | 34 | 3 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.99e-04 | 76 | 34 | 3 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.30e-03 | 90 | 34 | 3 | M631 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.48e-03 | 94 | 34 | 3 | M2843 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 18824173 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 10479448 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 33169406 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15256537 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8661043 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15797953 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 34475397 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21510948 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7798260 | ||
| Pubmed | Peripherally administered orexin improves survival of mice with endotoxin shock. | 1.23e-06 | 2 | 39 | 2 | 28035899 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27237973 | ||
| Pubmed | Comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2". | 1.23e-06 | 2 | 39 | 2 | 26582896 | |
| Pubmed | Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. | 1.23e-06 | 2 | 39 | 2 | 26950369 | |
| Pubmed | Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. | 1.23e-06 | 2 | 39 | 2 | 11723285 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 28000152 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 22389503 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38199807 | ||
| Pubmed | Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. | 1.23e-06 | 2 | 39 | 2 | 21377495 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 18714784 | ||
| Pubmed | Association of orexin receptor polymorphisms with antipsychotic-induced weight gain. | 1.23e-06 | 2 | 39 | 2 | 26447462 | |
| Pubmed | Cellular localization of orexin receptors in human pituitary. | 1.23e-06 | 2 | 39 | 2 | 11443222 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27683906 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20576035 | ||
| Pubmed | Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala. | 1.23e-06 | 2 | 39 | 2 | 24485472 | |
| Pubmed | Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice. | 1.23e-06 | 2 | 39 | 2 | 21533254 | |
| Pubmed | Orexin 1 and 2 Receptors in the Prelimbic Cortex Modulate Threat Valuation. | 1.23e-06 | 2 | 39 | 2 | 34126185 | |
| Pubmed | Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene. | 1.23e-06 | 2 | 39 | 2 | 21666548 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26996108 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 27988352 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20658214 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 11313359 | ||
| Pubmed | 1.71e-06 | 21 | 39 | 3 | 24157949 | ||
| Pubmed | Changes in orexin (hypocretin) neuronal expression with normal aging in the human hypothalamus. | 3.67e-06 | 3 | 39 | 2 | 25212464 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 9491897 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27847137 | ||
| Pubmed | Obesity and the hypothalamus: novel peptides for new pathways. | 3.67e-06 | 3 | 39 | 2 | 9491885 | |
| Pubmed | Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. | 3.67e-06 | 3 | 39 | 2 | 23034387 | |
| Pubmed | To eat or to sleep? Orexin in the regulation of feeding and wakefulness. | 3.67e-06 | 3 | 39 | 2 | 11283317 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 9527442 | ||
| Pubmed | Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. | 3.67e-06 | 3 | 39 | 2 | 29784823 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24530395 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 10516436 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 10896944 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 26907809 | ||
| Pubmed | Genetic analysis of the role of proteolysis in the activation of latent myostatin. | 3.67e-06 | 3 | 39 | 2 | 18286185 | |
| Pubmed | Internal and external modulation factors of the orexin system (REVIEW). | 3.67e-06 | 3 | 39 | 2 | 37054895 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20043912 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11340621 | ||
| Pubmed | Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. | 3.67e-06 | 3 | 39 | 2 | 21525292 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 16507574 | ||
| Pubmed | Absence of mutations in HCRT, HCRTR1 and HCRTR2 in patients with ROHHAD. | 3.67e-06 | 3 | 39 | 2 | 26555080 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 19079247 | ||
| Pubmed | Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models. | 3.67e-06 | 3 | 39 | 2 | 28507129 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24969517 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 10973318 | ||
| Pubmed | Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice. | 3.67e-06 | 3 | 39 | 2 | 24419319 | |
| Pubmed | Differential Roles of Each Orexin Receptor Signaling in Obesity. | 3.67e-06 | 3 | 39 | 2 | 31546102 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12808086 | ||
| Pubmed | BMP1 and TLL1 Are Required for Maintaining Periodontal Homeostasis. | 3.67e-06 | 3 | 39 | 2 | 28068493 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24794976 | ||
| Pubmed | A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. | 3.67e-06 | 3 | 39 | 2 | 1537334 | |
| Pubmed | Association between major mood disorders and the hypocretin receptor 1 gene. | 3.67e-06 | 3 | 39 | 2 | 21071097 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 34472713 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 31983458 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 30326460 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24005305 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 32209430 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10331975 | ||
| Pubmed | Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy. | 7.34e-06 | 4 | 39 | 2 | 33247179 | |
| Pubmed | Mammalian tolloid proteinases: role in growth factor signalling. | 7.34e-06 | 4 | 39 | 2 | 27391803 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 25249578 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 19694625 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15070969 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15978554 | ||
| Pubmed | BMP1-like proteinases are essential to the structure and wound healing of skin. | 7.34e-06 | 4 | 39 | 2 | 27363389 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 22028875 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12393877 | ||
| Pubmed | The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. | 1.22e-05 | 5 | 39 | 2 | 9419374 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 24268496 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 21378163 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 24763339 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 27631554 | ||
| Pubmed | An interspecific backcross linkage map of the proximal half of mouse chromosome 14. | 5.48e-05 | 10 | 39 | 2 | 1971251 | |
| Pubmed | The imprinted gene Magel2 regulates normal circadian output. | 5.48e-05 | 10 | 39 | 2 | 17893678 | |
| Pubmed | HIV-1 Tat-mediated apoptosis in human blood-retinal barrier-associated cells. | 6.70e-05 | 11 | 39 | 2 | 24739951 | |
| Pubmed | Chromosomal localization of three pulmonary surfactant protein genes in the mouse. | 9.48e-05 | 13 | 39 | 2 | 1346779 | |
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 19914233 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.03e-04 | 1105 | 39 | 7 | 35748872 | |
| Pubmed | Cell-Intrinsic Control of Interneuron Migration Drives Cortical Morphogenesis. | 2.07e-04 | 19 | 39 | 2 | 29474907 | |
| Pubmed | 2.07e-04 | 19 | 39 | 2 | 23666240 | ||
| Pubmed | Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development. | 3.05e-04 | 23 | 39 | 2 | 25875176 | |
| Pubmed | KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5. | 3.05e-04 | 23 | 39 | 2 | 28164238 | |
| Pubmed | 3.62e-04 | 25 | 39 | 2 | 19304889 | ||
| Pubmed | 5.04e-04 | 1285 | 39 | 7 | 35914814 | ||
| Pubmed | 8.84e-04 | 39 | 39 | 2 | 33580754 | ||
| Pubmed | Common genetic variation and the control of HIV-1 in humans. | 9.30e-04 | 40 | 39 | 2 | 20041166 | |
| Pubmed | 9.92e-04 | 689 | 39 | 5 | 36543142 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.09e-03 | 180 | 39 | 3 | 30110629 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 5.92e-03 | 135 | 39 | 2 | chr8p21 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.00e-07 | 6 | 32 | 3 | 894 | |
| GeneFamily | Hypocretin receptors | 3.03e-06 | 2 | 32 | 2 | 228 | |
| GeneFamily | WD repeat domain containing | 8.99e-05 | 262 | 32 | 5 | 362 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.04e-07 | 187 | 39 | 5 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.00e-07 | 198 | 39 | 5 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.83e-05 | 180 | 39 | 4 | 806e2f6138b630b9d7c41df75ec208e0a2298ee0 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-05 | 182 | 39 | 4 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 185 | 39 | 4 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 2.12e-05 | 187 | 39 | 4 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.12e-05 | 187 | 39 | 4 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 188 | 39 | 4 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.21e-05 | 189 | 39 | 4 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.26e-05 | 190 | 39 | 4 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.26e-05 | 190 | 39 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-05 | 191 | 39 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-05 | 191 | 39 | 4 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-05 | 192 | 39 | 4 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-05 | 192 | 39 | 4 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 193 | 39 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 193 | 39 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.40e-05 | 193 | 39 | 4 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 193 | 39 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 194 | 39 | 4 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 194 | 39 | 4 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 197 | 39 | 4 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-05 | 198 | 39 | 4 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.65e-05 | 198 | 39 | 4 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.39e-05 | 97 | 39 | 3 | 0d68bf2dfb9c221375b70b055f735536afb18f65 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 108 | 39 | 3 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Mixed_Serous_and_Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.39e-04 | 115 | 39 | 3 | c724e8b1fddcefdaa8d247aaff68c986538068f7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 129 | 39 | 3 | 64768adf23123b92280fb30eb85147cbee084ae0 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 140 | 39 | 3 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 140 | 39 | 3 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 140 | 39 | 3 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.70e-04 | 144 | 39 | 3 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 147 | 39 | 3 | 2885978bcfc5623967c0c1204dadf5c78c74a082 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.92e-04 | 148 | 39 | 3 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.92e-04 | 148 | 39 | 3 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 149 | 39 | 3 | 7e295b2b82dea0754e98f8cef788e2781e5d641f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 149 | 39 | 3 | b4f77dc5f9d08b249fe5cd9a0acf86308c528ef4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.10e-04 | 151 | 39 | 3 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.74e-04 | 161 | 39 | 3 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.74e-04 | 161 | 39 | 3 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 163 | 39 | 3 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.23e-04 | 168 | 39 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.38e-04 | 170 | 39 | 3 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-04 | 173 | 39 | 3 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.69e-04 | 174 | 39 | 3 | 43c0e758fa8683708475aec846929ac70d41d7f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.69e-04 | 174 | 39 | 3 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.69e-04 | 174 | 39 | 3 | 667035a11b68745fa8446d6c68214713be42710f | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.69e-04 | 174 | 39 | 3 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-04 | 175 | 39 | 3 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 176 | 39 | 3 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-04 | 176 | 39 | 3 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.85e-04 | 176 | 39 | 3 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 176 | 39 | 3 | 086197acbfec4ac0c15b7e9721871aaa9e32e219 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-04 | 176 | 39 | 3 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.93e-04 | 177 | 39 | 3 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.93e-04 | 177 | 39 | 3 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.93e-04 | 177 | 39 | 3 | 5e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.93e-04 | 177 | 39 | 3 | 675003fbecee1b86919d1a6eeb268e1ca298f714 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.93e-04 | 177 | 39 | 3 | 72d144289167f200ac9f006d130de31e45568484 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.93e-04 | 177 | 39 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.93e-04 | 177 | 39 | 3 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-2_PVALB_TAC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 178 | 39 | 3 | 1985271984e6747941c8d2097d9c58f0260f021a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 178 | 39 | 3 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.01e-04 | 178 | 39 | 3 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.01e-04 | 178 | 39 | 3 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.09e-04 | 179 | 39 | 3 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.09e-04 | 179 | 39 | 3 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-04 | 179 | 39 | 3 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.18e-04 | 180 | 39 | 3 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 180 | 39 | 3 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.18e-04 | 180 | 39 | 3 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 181 | 39 | 3 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-04 | 181 | 39 | 3 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.26e-04 | 181 | 39 | 3 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 5.35e-04 | 182 | 39 | 3 | 84018a84e1aa52fa52ccfc26db9cd1fb6d535b31 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.35e-04 | 182 | 39 | 3 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-04 | 182 | 39 | 3 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.35e-04 | 182 | 39 | 3 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.35e-04 | 182 | 39 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.35e-04 | 182 | 39 | 3 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-04 | 182 | 39 | 3 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.35e-04 | 182 | 39 | 3 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.43e-04 | 183 | 39 | 3 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.43e-04 | 183 | 39 | 3 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.43e-04 | 183 | 39 | 3 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.52e-04 | 184 | 39 | 3 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.61e-04 | 185 | 39 | 3 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.61e-04 | 185 | 39 | 3 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 185 | 39 | 3 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.61e-04 | 185 | 39 | 3 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-04 | 185 | 39 | 3 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.61e-04 | 185 | 39 | 3 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 186 | 39 | 3 | aeac0c2db173cd1ea45b5052ab418d6cacd198d8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-04 | 186 | 39 | 3 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 186 | 39 | 3 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 186 | 39 | 3 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.06e-06 | 199 | 39 | 6 | 3541_UP | |
| Drug | milnacipran | 1.71e-05 | 4 | 39 | 2 | ctd:C048107 | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.99e-05 | 195 | 39 | 5 | 6039_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 39 | 5 | 2424_DN | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A | 2.25e-05 | 200 | 39 | 5 | 2116_UP | |
| Disease | HIV-1 infection | 2.75e-04 | 98 | 38 | 3 | EFO_0000180 | |
| Disease | mood instability measurement | 6.02e-04 | 128 | 38 | 3 | EFO_0008475 | |
| Disease | Global developmental delay | 6.73e-04 | 133 | 38 | 3 | C0557874 | |
| Disease | Malignant neoplasm of liver | 8.14e-04 | 142 | 38 | 3 | C0345904 | |
| Disease | Liver neoplasms | 8.14e-04 | 142 | 38 | 3 | C0023903 | |
| Disease | neuroticism measurement | 9.99e-04 | 909 | 38 | 6 | EFO_0007660 | |
| Disease | diverticulitis | 1.05e-03 | 37 | 38 | 2 | EFO_1001460 | |
| Disease | testicular carcinoma | 1.22e-03 | 40 | 38 | 2 | EFO_0005088 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.54e-03 | 45 | 38 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | glucose-dependent insulinotropic peptide measurement | 2.14e-03 | 53 | 38 | 2 | EFO_0008464 | |
| Disease | depressive symptom measurement | 2.14e-03 | 426 | 38 | 4 | EFO_0007006 | |
| Disease | susceptibility to hepatitis B infection measurement | 3.10e-03 | 64 | 38 | 2 | EFO_0008405 | |
| Disease | obstructive sleep apnea | 3.29e-03 | 66 | 38 | 2 | EFO_0003918 | |
| Disease | coronary artery disease | 3.94e-03 | 1194 | 38 | 6 | EFO_0001645 | |
| Disease | Testicular Germ Cell Tumor | 4.01e-03 | 73 | 38 | 2 | EFO_1000566 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WMALECIHYRKFTHQ | 886 | Q15303 | |
| RFVVDFMLHHCIARW | 156 | Q16611 | |
| HCVMKESVREQWQIH | 2986 | Q8IZF6 | |
| MRWHHRTTVSNVKMD | 196 | P22352 | |
| FRQAMRHWEKHTCVT | 151 | P13497 | |
| AVDHMEICHSNMLRW | 231 | Q9H816 | |
| HTKRMQHVICVKWTS | 321 | Q9NV06 | |
| HHSIRCMAVVYDRVW | 1046 | Q9UPT6 | |
| MMRIKTWHFSIRQHR | 191 | Q86U70 | |
| DCKREFSWMVRRHHC | 1181 | Q9BQS8 | |
| LLHMHRNWKRSTECA | 1826 | O60318 | |
| QRRMHTLWQEHFKLV | 801 | Q5BJE1 | |
| AMHQVWVKFDIRGHC | 676 | O43593 | |
| VWKQRTHVMRFFHET | 96 | P56556 | |
| VWFQNCRARHKKHVS | 271 | Q68G74 | |
| LVCLAVWRNHHMRTV | 66 | O43613 | |
| CVAVWKNHHMRTVTN | 76 | O43614 | |
| VTARHCVWCRMTFHR | 361 | P49619 | |
| MVHVCWHRNTSVSMV | 911 | Q9Y4F1 | |
| RSDCMAANYRWVHHK | 1346 | Q9P0X4 | |
| KSAWRAFKESQCHHM | 41 | Q8J025 | |
| HRKVAQIFVTMHWSV | 2946 | Q9P225 | |
| VAMCHKFHVCIEWRR | 2351 | Q6ZRI0 | |
| WMSRLHFCDSNVVRH | 161 | Q8NGG4 | |
| QVHMSRHFKVWSLRR | 361 | O60391 | |
| AMRHWEKHTCVTFIE | 181 | O43897 | |
| ETVTYMTHCHSRIEW | 96 | Q6ZMZ3 | |
| HVWRSHSTKSVMDFV | 1356 | Q8NFP9 | |
| WCMRHTFASSRHKYE | 656 | A1L4K1 | |
| IMKRRVHTHWDVNIS | 81 | Q96NU1 | |
| ICMFRWHTHQKGKVV | 176 | Q8IZU2 | |
| LIERTMMVNCHAHFW | 161 | Q8IZV5 | |
| NICAKRFMWRDSFHR | 431 | O43298 | |
| RFMWRDSFHRHVTSC | 436 | O43298 | |
| MIFQHLCCRWRKHES | 1181 | Q9HCF6 | |
| RWVVTAAHCMHSFRL | 251 | Q9H3S3 | |
| KQAMRHWEKHTCVTF | 181 | Q9Y6L7 | |
| HTSHMMEWFRTQEVC | 946 | Q6PJI9 | |
| QHCFKTMVGHRTEVW | 181 | Q9UNX4 | |
| SCKHWVRHCEAMETR | 376 | Q6BDS2 | |
| TIQKHVRGWMARRHF | 866 | Q9ULV0 |